Formulation, Development and Evaluation of Ibuprofen Loaded Nano-transferosomal Gel for the Treatment of Psoriasis

Main Article Content

Marwa H. Abdallah
Amr S. Abu Lila
Md. Khalid Anwer
El-Sayed Khafagy
Muqtader Mohammad
Mahmoud S. Soliman

Abstract

The present work was aimed to develop a transferosomal gel of ibuprofen (IBU) for the amelioration of psoriasis like inflammation. Three formulation of IBU loaded transferosomes (TFs1-TFs3) were prepared using different proportions of lipid (phospholipon 90H) and surfactant (tween 80) and further evaluated for vesicle size, zeta potential (ZP), entrapment efficiency and in vitro drug release. The IBU loaded transferosomes (TFs2) was optimized with vesicle size (217±8.4 nm), PDI (0.102), ZP (-31.5±4.3 mV), entrapment efficiency (88.4±6.9%) and drug loading (44.2±2.9%). Further, the optimized IBU loaded transferosomes (TFs2) was incorporated into 1% carbopol 934 gel base and characterized for homogeneity, extrudability, viscosity and drug content. The in vivo pharmacodynamic study of gel exhibited reduction in psoriasis like inflammation in mice. The ibuprofen loaded transferosomal gel was successfully developed and has shown the potential to be a new therapy against psoriasis like inflammation.

Keywords:
Ibuprofen, transferosomes, gel, psoriasis.

Article Details

How to Cite
Abdallah, M. H., Lila, A. S. A., Anwer, M. K., Khafagy, E.-S., Mohammad, M., & S. Soliman, M. (2019). Formulation, Development and Evaluation of Ibuprofen Loaded Nano-transferosomal Gel for the Treatment of Psoriasis. Journal of Pharmaceutical Research International, 31(6), 1-8. https://doi.org/10.9734/jpri/2019/v31i630356
Section
Original Research Article

References

Oji V, Luger TA. The skin in psoriasis: Assessment and challenges. Clin Exp Rheumatol. 2015;33:S14-9.

Boehncke WH, Schön MP. Psoriasis. Lancet. 2015;386:983-94.

Keating GM. Apremilast: A Review in psoriasis and psoriatic arthritis. Drugs. 2017;77:459-472.

Gisondi P, Del Giglio M, Girolomoni G. Treatment Approaches to Moderate to Severe Psoriasis. Int J Mol Sci. 2017;18: E2427.

Anwer MK, Mohammad M, Ezzeldin E, Fatima F, Alalaiwe A, Iqbal M. Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats. Int J Nano-medicine. 2019;14:1587-1595.

Yeung H, Takeshita J, Mehta NN, Kimmel SE, Ogdie A, Margolis DJ, Gelfand JM. Psoriasis severity and the prevalence of major medical comorbidity: A population-based study. JAMA dermatology. 2013; 149:1173–1179.

Thappa DM, Malathi M. Topical therapy of psoriasis: Where do we stand? J Postgrad Med. 2017;63:210–212.

Garg T, Rath G, Goyal AK. Comprehensive review on additives of topical dosage forms for drug delivery. Drug Deliv. 2015;22:969-987.

Azeem A, Anwer MK, Talegaonkar S. Niosomes in sustained and targeted drug delivery: Some recent advances. J Drug Target. 2009;17:671-89.

Hua S. Lipid-based nano-delivery systems for skin delivery of drugs and bioactives. Front. Pharmacol. 2015;6:219.

Benson HA. Transfersomes for transdermal drug delivery. Expert Opin Drug Deliv. 2006;3:727-737.

Irfan M, Verma S, Ram A. Preparation and characterization of ibuprofen loaded transferosome as a novel carrier for transdermal drug delivery system. Asian J Pharm Clin Res.2012;5:162-165.

Rajan R, Jose S, Mukund, VP, & Vasudevan DT. Transferosomes - A vesicular transdermal delivery system for enhanced drug permeation. J Adv Pharm Technol Res. 2011;2:138–143.

Ali MF, Salem HF, Abdelmohsen HF, Attia SK. Preparation and clinical evaluation of nano-transferosomes for treatment of erectile dysfunction. Drug Des Devel Ther. 2015;9:2431-47.

Bushra R, Aslam N. An overview of clinical pharmacology of Ibuprofen. Oman Med J. 2010;25:155–1661.

Newa M, Bhandari KH, Kim JO, Im JS, Kim JA, Yoo BK, Woo JS, Choi HG, Yong CS. Enhancement of solubility, dissolution and bioavailability of ibuprofen in solid dispersion systems. Chem Pharm Bull (Tokyo). 2008;56:569-74.

Yong CS, Lee MK, Park YJ, Kong KH, Xuan JJ, Kim JH, Kim JA, Lyoo WS, Han SS, Rhee JD, Kim JO, Yang CH, Kim CK, Choi HG. Enhanced oral bioavailability of ibuprofen in rats by poloxamer gel using poloxamer 188 and menthol. Drug Dev Ind Pharm. 2005;31: 615-22.

Omar MM, Hasan OA, El Sisi AM. Preparation and optimization of lidocaine transferosomal gel containing permeation enhancers: A promising approach for enhancement of skin permeation. Int J Nanomed. 2019;14:1551–1562.

Anwer MK, Al-Shdefat R, Ezzeldin E, Alshahrani SM, Alshetaili AS, Iqbal M. Preparation, evaluation and bioavailability studies of eudragit coated PLGA nanoparticles for sustained release of eluxadoline for the treatment of irritable bowel syndrome. Front Pharmacol. 2017; 8:844.

Hasnain MS, Nayak AK. Solubility and dissolution enhancement of ibuprofen by solid dispersion technique using peg 6000-PVP K- 30 combination carrier. Bulgarian J Sci Edu. 2012;21:118-132.

Singh S, Verma D, Mirza MA, Das AK, Dudeja M, Anwer MK, Talegaonkar S, Iqbal Z. Development and optimization of ketoconazole loaded nano-transfersomal gel for vaginal delivery using Box-Behnken design: In vitro, ex vivo characterization and antimicrobial evaluation. J Drug DelivSci Technol. 2017;39:95-103.

van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated viathe IL-23/IL-17 axis. J Immunol.2009;182:5836–45.

Horváth S, Komlódi R, Perkecz A, Pintér E, Gyulai R, Kemény A. Methodological refinement of Aldara-induced psoriasiform dermatitis model in mice. Scientific Reports. 2019;9:3685.